<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d232">
    <sentence id="DDI-MedLine.d232.s0" text="Stroke prevention in atrial fibrillation: current status and near-future directions.&#xd;&#xa;"/>
    <sentence id="DDI-MedLine.d232.s1" text="Prevention of atrial fibrillation-related stroke is an important part of atrial fibrillation management. "/>
    <sentence id="DDI-MedLine.d232.s2" text="However, stroke risk is not homogeneous and varies with associated morbidities and risk factors. "/>
    <sentence id="DDI-MedLine.d232.s3" text="Risk stratification schemes have been developed that categorize patients' stroke risk into classes based on a combination of risk factors. "/>
    <sentence id="DDI-MedLine.d232.s4" text="According to the calculated level of risk, guidelines recommend patients with atrial fibrillation receive antithrombotic therapy either as a vitamin K antagonist or aspirin. ">
        <entity id="DDI-MedLine.d232.s4.e0" charOffset="106-119"
            type="group" text="antithrombotic"/>
        <entity id="DDI-MedLine.d232.s4.e1" charOffset="141-160"
            type="group" text="vitamin K antagonist"/>
        <entity id="DDI-MedLine.d232.s4.e2" charOffset="165-171"
            type="brand" text="aspirin"/>
        <pair id="DDI-MedLine.d232.s4.p0" e1="DDI-MedLine.d232.s4.e0"
            e2="DDI-MedLine.d232.s4.e1" ddi="false"/>
        <pair id="DDI-MedLine.d232.s4.p1" e1="DDI-MedLine.d232.s4.e0"
            e2="DDI-MedLine.d232.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d232.s4.p2" e1="DDI-MedLine.d232.s4.e1"
            e2="DDI-MedLine.d232.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d232.s5" text="Despite recommendations, however, many patients with atrial fibrillation do not receive adequate thromboprophylaxis. "/>
    <sentence id="DDI-MedLine.d232.s6" text="We will discuss some of the underlying reasons, in part related to the drawbacks associated with vitamin K antagonists. ">
        <entity id="DDI-MedLine.d232.s6.e0" charOffset="97-117"
            type="group" text="vitamin K antagonists"/>
    </sentence>
    <sentence id="DDI-MedLine.d232.s7" text="These highlight the need for new anticoagulants in atrial fibrillation. ">
        <entity id="DDI-MedLine.d232.s7.e0" charOffset="33-46"
            type="group" text="anticoagulants"/>
    </sentence>
    <sentence id="DDI-MedLine.d232.s8" text="The novel oral anticoagulants in development may overcome some of the limitations of vitamin K antagonists and address their underuse and safety concerns.">
        <entity id="DDI-MedLine.d232.s8.e0" charOffset="15-28"
            type="group" text="anticoagulants"/>
        <entity id="DDI-MedLine.d232.s8.e1" charOffset="85-105"
            type="group" text="vitamin K antagonists"/>
        <pair id="DDI-MedLine.d232.s8.p0" e1="DDI-MedLine.d232.s8.e0"
            e2="DDI-MedLine.d232.s8.e1" ddi="false"/>
    </sentence>
</document>
